Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, overall manufacturer performance, overall system performance and overall service performance in the ServiceTrak Imaging 2018 report on radiation oncology accelerator manufacturers published by IMV Medical Information Division.
PALO ALTO, Calif., /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, overall manufacturer performance, overall system performance and overall service performance in the ServiceTrak Imaging 2018 report on radiation oncology accelerator manufacturers published by IMV Medical Information Division. The rankings are based on surveys of customers conducted by IMV. Varian ranked first in the following categories this year:
"We are proud and honored to once again receive these top rankings from our customers, and it validates the ongoing commitment of Varian employees to develop strong partnerships in the fight against cancer," said Chris Toth, president of Varian's Oncology Systems business. "In addition to these rankings, we are also very pleased that the 2018 IMV report also showed Varian had the highest Net Promoter Score at 71 percent, compared to the industry average of 53 percent. This score represents the likelihood a customer would recommend a manufacturer to a colleague." About Varian About IMV Press Contact Mark Plungy Investor Relations Contact J. Michael Bruff
SOURCE Varian |
||
Company Codes: NYSE:VAR |